Kenneth S. Polonsky to Treatment Outcome
This is a "connection" page, showing publications Kenneth S. Polonsky has written about Treatment Outcome.
Connection Strength
0.107
-
Gastric banding to treat obesity: band-aid or breakthrough? Nat Clin Pract Endocrinol Metab. 2008 Aug; 4(8):421.
Score: 0.034
-
A significant role for histocompatibility in human islet transplantation. Transplantation. 2006 Jul 27; 82(2):180-7.
Score: 0.029
-
Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance. J Clin Invest. 1997 Aug 01; 100(3):530-7.
Score: 0.016
-
Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes. Am J Physiol Gastrointest Liver Physiol. 2014 Feb 15; 306(4):G301-9.
Score: 0.012
-
Ginseng and ginsenoside Re do not improve ß-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetes. Diabetes Care. 2011 May; 34(5):1071-6.
Score: 0.010
-
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes. 2004 Jan; 53(1):250-64.
Score: 0.006